Related Experiment Video
Updated: Jul 19, 2025

Using In Vitro Fluorescence Resonance Energy Transfer to Study the Dynamics Of Protein Complexes at a Millisecond Time Scale
Published on: March 14, 2019
Structure and Function of RhoBTB1 Required for Substrate Specificity and Cullin-3 Ubiquitination
Gaurav Kumar1, Shi Fang1, Daria Golosova1
1Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Rho-related BTB domain containing 1 (RhoBTB1) regulates vascular tone by controlling phosphodiesterase 5 (PDE5) activity. RhoBTB1 targets PDE5 for degradation via the Cullin-3 (CUL3) complex, influencing SETD2 levels.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- Vascular tone regulation is crucial for cardiovascular health.
- Phosphodiesterase 5 (PDE5) plays a significant role in modulating vascular smooth muscle relaxation.
- Understanding the upstream regulators of PDE5 activity is essential for developing novel therapeutic strategies.
Purpose of the Study:
- To identify novel regulators of phosphodiesterase 5 (PDE5) activity.
- To elucidate the molecular mechanisms by which Rho-related BTB domain containing 1 (RhoBTB1) controls PDE5.
- To investigate the downstream targets and functional consequences of the RhoBTB1-PDE5 interaction.
Main Methods:
- Truncation analysis of RhoBTB1 to identify functional domains.
- Co-immunoprecipitation assays to confirm protein-protein interactions.
- Site-directed mutagenesis to pinpoint key amino acid residues.
- Ascorbate peroxidase 2 (APEX2) proximity labeling to identify novel binding partners.
- siRNA-mediated knockdown and pharmacological inhibition to study protein regulation.
Main Results:
- Rho-related BTB domain containing 1 (RhoBTB1) directly binds to and targets phosphodiesterase 5 (PDE5) for proteasomal degradation via the Cullin-3 (CUL3) E3 ubiquitin ligase complex.
- The C-terminal half of RhoBTB1, specifically the C-terminal domain, is essential for PDE5 recruitment and degradation.
- Key residues Pro353 and Ser363 in RhoBTB1 are critical for CUL3 binding, impacting PDE5 degradation.
- SET domain containing 2 (SETD2) was identified as a novel RhoBTB1 binding partner, and its levels are regulated by the RhoBTB1-CUL3 axis.
Conclusions:
- RhoBTB1 acts as a key regulator of vascular tone through its control of PDE5 activity and degradation.
- The RhoBTB1-CUL3 complex mediates the ubiquitination and proteasomal degradation of PDE5.
- SETD2 is a novel downstream effector regulated by the RhoBTB1-CUL3 pathway, suggesting a broader role in cellular processes.
- Further investigation is warranted to determine the role of SETD2 in cardiovascular function.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Receptor Tyrosine Kinases
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...

